Lymphadenopathy study
Clinical study in children with enlarged lymph nodes to better predict the underlying cause.
Recruiting
Who can enter
Children with enlarged lymph nodes
Age: 0-18 years
Goal
Goal
The goal of this study is to collect data and do an additional blood analysis in children who come to the hospital because of an enlarged lymph node. With this data, we want to create a tool that will help pediatricians to predict the cause of the enlarged lymph node better and faster in the future.
Background
Background
An enlarged lymph node is common in children and adolescents. In most cases, the cause is not serious and it is caused, for example, by a cold or inflammation of the lymph node. However, sometimes the lymph node can be enlarged due to a form of lymph node cancer. The cause of the enlarged lymph node can be difficult to recognize with physical examination, standard blood tests and imaging. To be sure, patients often have to undergo surgery that removes the entire lymph node or a biopsy. Too often patients are unnecessarily referred to a specialized hospital. Uncertainty about the cause of an enlarged gland also gives children and parents a lot of stress until the diagnosis is known.
We would like to be able to predict better and faster in which children the cause is serious and in which children it is not. Therefore, we want to collect data from a large group of children and take additional blood measurements. With this data, we want to develop a tool that can predict the cause of the enlarged lymph nodes in future patients. As a result, fewer children will need surgery in the future. Moreover, fewer children will be unnecessarily referred to a specialized hospital and children and parents will experience less stress while waiting for the diagnosis.
In order to participate in a study please refer to your/your child’s doctor.
Last reviewed
Last reviewed
October 16, 2025
Study details
- Study details
Official title
Optimal diagnostics for timely recognition of suspected malignancy and avoiding unnecessary referral of benign causes in children with lymphadenopathy.Disease
Children with enlarged lymph nodesMaximum number of participants
Minimum of 440 patients, all in the NetherlandsStart date
October 16, 2025Status
Open for inclusionLocal principal investigator
Dr. Friederike Meyer-WentrupSponsor
Princess Máxima Center for pediatric oncologyApproval
This study has been reviewed by an accredited medical research ethics committee. This committee has decided that it is justified to ask patients to participate in this study. More information can be found at: CCMO.Trial registry number
CCMO onderzoekmetmensen.nl: NL-009186
The above information is intended as a brief summary only and may not reflect the most up-to-date information. For full details and the current status of a protocol, physicians can contact the Princess Máxima Center directly.